Suchergebnisse - "Gyawali, Bishal"

PubPharm (17)

1

Expensive Drug Prices for Rare Cancers : Are Patients Truly Benefitting?

enthalten in: HealthcarePapers | 2023

von Jenei, K. | Gyawali, B.

CommentOn: Healthc Pap. 2023 Jan;21(1):10-26. - PMID 36692912

2

Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials-Reply

enthalten in: JAMA oncology | 2022

von Gyawali, B. | Eisenhauer, E. | Brundage, M.

CommentOn: JAMA Oncol. 2022 Jun 1;8(6):879-886. - PMID 35482347

3

Aumolertinib in EGFR-Mutant Lung Cancer : Will the Promise of Cost Disruption Ease Access?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Aggarwal, C. | Gyawali, B.

CommentOn: J Clin Oncol. 2022 Sep 20;40(27):3162-3171. - PMID 35580297

4

Radiographic progression-free survival in the ACIS trial for prostate cancer

enthalten in: The Lancet. Oncology | 2022

von Tannock, I. | Booth, C. | Gyawali, B. | +1

CommentOn: Lancet Oncol. 2021 Nov;22(11):1541-1559. - PMID 34600602

5

Risk of COVID-19 in Patients With Cancer

enthalten in: JAMA oncology | 2020

von Robinson, A. | Gyawali, B. | Booth, C.

CommentOn: JAMA Oncol. 2020 Jul 1;6(7):1108-1110. - PMID 32211820

6

Plasma vs Tissue Next-Generation Sequencing in Non-Small Cell Lung Cancer-Either, Both, or Neither?

enthalten in: JAMA oncology | 2019

von Gyawali, B. | West, H.

CommentOn: JAMA Oncol. 2019 Feb 1;5(2):173-180. - PMID 30325992

7

Information Transparency in the Drug Approval Process-Reply

enthalten in: JAMA oncology | 2018

von Gyawali, B. | Goldstein, D.

CommentOn: JAMA Oncol. 2018 May 1;4(5):623-624. - PMID 29522146

8

Reinforcing the social compromise of accelerated approval

enthalten in: Nature reviews. Clinical oncology | 2018

von Gyawali, B. | Kesselheim, A.

CommentOn: JAMA Oncol. 2018 Jul 1;4(7):993-994. - PMID 29801111

9

What Global Oncology Needs : Mutual Learning and More Funding

enthalten in: Journal of global oncology | 2018

von Gyawali, B. | Lopes, G.

CommentOn: J Glob Oncol. 2018 Sep;4:1-11. - PMID 30241245

10

FDA Approval Summary : Sonidegib-Letter

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Gyawali, B. | Ando, Y.

CommentOn: Clin Cancer Res. 2017 May 15;23(10):2377-2381. - PMID 28073840